MPE will hold a webinar on ASH 2018 highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, MPE, MyelomaJanuary 16, 2019
New data presented at ASH 2018 from an ongoing phase I clinical trial of CAR T cell therapy in relapsed/refractory myelomaConferences, MyelomaDecember 4, 2018
Trust in non-conventional therapies by cancer patients not matched with proper awareness about their risksConferencesOctober 11, 2018
Denosumab delays the time to first skeletal-related event in patients with myelomaConferences, MyelomaJune 5, 2017
